Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Andress

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Kidney International|September 1, 1989
Plasma insulin-like growth factors and bone formation in uremic hyperparathyroidismD L Andress, M R Pandian, D B Endres, et al.
Kidney International|February 8, 2008
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney diseaseO M Gutiérrez, T Isakova, D L Andress, et al.
Arctic Medical Research|January 1, 1993
The health of the Inuit of North America. A bibliography from the earliest times through 1990R Fortuine, J Braund-Allen, J Alward, et al.
Journal of Advanced Nursing|August 24, 1999
Health characteristics of elderly personal care home residentsM E Quinn, M A Johnson, E L Andress, et al.
Skeletal Radiology|January 1, 1996
Magnetic resonance imaging of dialysis-related amyloidosis of the shoulder and hipE M Escobedo, J C Hunter, G C Zink-Brody, et al.
Clinical Drug Investigation|July 1, 2010
Cost Effectiveness of Paricalcitol versus a non-selective vitamin D receptor activator for secondary hyperparathyroidism in the UK: a chronic kidney disease markov modelMark Nuijten, Dennis L Andress, Steven E Marx, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|June 22, 2013
Promoting dietary diversity to improve child growth in less-resourced rural settings in UgandaM K Kabahenda, E L Andress, S Y Nickols, et al.
Life Sciences|February 14, 2012
Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD)Dennis L Andress, Blai Coll, Yili Pritchett, et al.
Kidney International|May 1, 1991
Beta 2-microglobulin deposition in bone in chronic renal failureS Onishi, D L Andress, N A Maloney, et al.
American Journal of Nephrology|December 18, 2009
Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patientsRichard J Lund, Dennis L Andress, Michael Amdahl, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Kidney International|September 1, 1989
Plasma insulin-like growth factors and bone formation in uremic hyperparathyroidismD L Andress, M R Pandian, D B Endres, et al.
Kidney International|February 8, 2008
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney diseaseO M Gutiérrez, T Isakova, D L Andress, et al.
Arctic Medical Research|January 1, 1993
The health of the Inuit of North America. A bibliography from the earliest times through 1990R Fortuine, J Braund-Allen, J Alward, et al.
Journal of Advanced Nursing|August 24, 1999
Health characteristics of elderly personal care home residentsM E Quinn, M A Johnson, E L Andress, et al.
Skeletal Radiology|January 1, 1996
Magnetic resonance imaging of dialysis-related amyloidosis of the shoulder and hipE M Escobedo, J C Hunter, G C Zink-Brody, et al.
Clinical Drug Investigation|July 1, 2010
Cost Effectiveness of Paricalcitol versus a non-selective vitamin D receptor activator for secondary hyperparathyroidism in the UK: a chronic kidney disease markov modelMark Nuijten, Dennis L Andress, Steven E Marx, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|June 22, 2013
Promoting dietary diversity to improve child growth in less-resourced rural settings in UgandaM K Kabahenda, E L Andress, S Y Nickols, et al.
Life Sciences|February 14, 2012
Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD)Dennis L Andress, Blai Coll, Yili Pritchett, et al.
Kidney International|May 1, 1991
Beta 2-microglobulin deposition in bone in chronic renal failureS Onishi, D L Andress, N A Maloney, et al.
American Journal of Nephrology|December 18, 2009
Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patientsRichard J Lund, Dennis L Andress, Michael Amdahl, et al.
Pageof 10